[1] |
SEIDL-PHILIPP M, FRISCHHUT N, HÖLLWEGER N, et al. Known and new facts on basal cell carcinoma[J]. J Dtsch Dermatol Ges, 2021, 19(7):1021-1041. doi:10.1111/ddg.14580.
|
[2] |
MARZUKA A G, BOOK S E. Basal cell carcinoma:pathogenesis,epidemiology,clinical features,diagnosis,histopathology,and management[J]. Yale J Biol Med, 2015, 88(2):167-179.
|
[3] |
BASSET-SEGUIN N, HERMS F. Update in the management of basal cell carcinoma[J]. Acta Derm Venereol, 2020, 100(11):adv00140. doi:10.2340/00015555-3495.
|
[4] |
ULUDAG S S, SANLI A N, ZENGIN A K, et al. Systemic inflammatory biomarkers as surrogate markers for stage in colon cancer[J]. Am Surg, 2022, 88(6):1256-1262. doi:10.1177/0003134821995059.
|
[5] |
NØST T H, ALCALA K, URBAROVA I, et al. Systemic inflammation markers and cancer incidence in the UK Biobank[J]. Eur J Epidemiol, 2021, 36(8):841-848. doi:10.1007/s10654-021-00752-6.
|
[6] |
NISHIJIMA T F, DEAL A M, LUND J L, et al. Inflammatory markers and overall survival in older adults with cancer[J]. J Geriatr Oncol, 2019, 10(2):279-284. doi:10.1016/j.jgo.2018.08.004.
|
[7] |
WANG Y, ZHANG H, YANG Y, et al. Prognostic value of peripheral inflammatory markers in preoperative mucosal melanoma:a multicenter retrospective study[J]. Front Oncol, 2019, 9:995. doi:10.3389/fonc.2019.00995.
|
[8] |
ZHU M, CHEN L, KONG X, et al. The systemic inflammation response index as an independent predictor of survival in breast cancer patients:a retrospective study[J]. Front Mol Biosci, 2022, 9:856064. doi:10.3389/fmolb.2022.856064.
|
[9] |
ZHOU S, YUAN H, WANG J, et al. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection[J]. Future Oncol, 2020, 16(10):559-571. doi:10.2217/fon-2020-0010.
|
[10] |
ZHANG R, HU C, ZHANG J, et al. Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer[J]. BMC Cancer, 2023, 23(1):5. doi:10.1186/s12885-022-10479-6.
|
[11] |
刘忠, 刘聪, 雷丽华, 等. 基底细胞癌复发风险水平分析[J]. 中国实用医药, 2021, 16(3):11-13.
|
|
LIU Z, LIU C, LEI L H, et al. Analysis of the risk level of recurrence in basal cell carcinoma[J]. Practical Medicine in China, 2021, 16(3):11-13. doi:10.14163/j.cnki.11-5547/r.2021.03.004.
|
[12] |
CHAN J C, CHAN D L, DIAKOS C I, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer[J]. Ann Surg, 2017, 265(3):539-546. doi:10.1097/SLA.0000000000001743.
|
[13] |
SHAU H Y, KIM A. Suppression of lymphokine-activated killer induction by neutrophils[J]. J Immunol, 1988, 141(12):4395-4402.
|
[14] |
MANTOVANI A, ALLAVENA P, SICA A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203):436-444. doi:10.1038/nature07205.
|
[15] |
YILMAZ H, CINAR N B, AVCI I E, et al. The systemic inflammation response index: an independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers[J]. Urol Oncol, 2023, 41(5):256.e1-256.e8. doi:10.1016/j.urolonc.2022.11.011.
|
[16] |
ARMSTRONG B K, KRICKER A. The epidemiology of UV induced skin cancer[J]. J Photochem Photobiol B, 2001, 63(1/3):8-18. doi:10.1016/s1011-1344(01)00198-1.
|
[17] |
TENG Y, YU Y, LI S, et al. Ultraviolet radiation and basal cell carcinoma:an environmental perspective[J]. Front Public Health, 2021, 9:666528. doi:10.3389/fpubh.2021.666528.
|
[18] |
SITUM M, BULJAN M, BULAT V, et al. The role of UV radiation in the development of basal cell carcinoma[J]. Coll Antropol, 2008, 32 Suppl 2:167-170.
|
[19] |
MORGAN F C, RUIZ E S, KARIA P S, et al. Factors predictive of recurrence,metastasis,and death from primary basal cell carcinoma 2 cm or larger in diameter[J]. J Am Acad Dermatol, 2020, 83(3):832-838. doi:10.1016/j.jaad.2019.09.075.
|